These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7936301)
1. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Del Brutto OH Neurology; 1994 Sep; 44(9):1706-9. PubMed ID: 7936301 [TBL] [Abstract][Full Text] [Related]
2. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial. Medina MT; Genton P; Montoya MC; Córdova S; Dravet C; Sotelo J Epilepsia; 1993; 34(6):1024-7. PubMed ID: 8243351 [TBL] [Abstract][Full Text] [Related]
3. The course of seizures after treatment for cerebral cysticercosis. Vazquez V; Sotelo J N Engl J Med; 1992 Sep; 327(10):696-701. PubMed ID: 1495522 [TBL] [Abstract][Full Text] [Related]
4. [Neurocysticercosis in children: clinical and radiological analysis and prognostic factors in 54 patients]. del Brutto OH Rev Neurol; 1997 Nov; 25(147):1681-4. PubMed ID: 9484517 [TBL] [Abstract][Full Text] [Related]
5. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. Garcia HH; Pretell EJ; Gilman RH; Martinez SM; Moulton LH; Del Brutto OH; Herrera G; Evans CA; Gonzalez AE; N Engl J Med; 2004 Jan; 350(3):249-58. PubMed ID: 14724304 [TBL] [Abstract][Full Text] [Related]
6. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. Singhi P; Jain V; Khandelwal N J Child Neurol; 2004 May; 19(5):323-7. PubMed ID: 15224704 [TBL] [Abstract][Full Text] [Related]
7. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Carpio A; Hauser WA Neurology; 2002 Dec; 59(11):1730-4. PubMed ID: 12473760 [TBL] [Abstract][Full Text] [Related]
8. Short course of albendazole therapy for neurocysticercosis. Sotelo J; Penagos P; Escobedo F; Del Brutto OH Arch Neurol; 1988 Oct; 45(10):1130-3. PubMed ID: 3178533 [TBL] [Abstract][Full Text] [Related]
9. T2 relaxometry helps prognosticate seizure outcome in patients with solitary cerebral cysticercosis. de Souza A; Nalini A; Saini J; Thennarasu K J Neurol Sci; 2017 May; 376():1-6. PubMed ID: 28431589 [TBL] [Abstract][Full Text] [Related]
10. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. Thussu A; Chattopadhyay A; Sawhney IM; Khandelwal N J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):272-5. PubMed ID: 17928325 [TBL] [Abstract][Full Text] [Related]
11. Treatment of neurocysticercosis with a two week course of albendazole. Chotmongkol V Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):396-8. PubMed ID: 8266251 [TBL] [Abstract][Full Text] [Related]
12. Albendazole therapy in ring lesions of neurocysticercosis. Lowalekar KB J Assoc Physicians India; 1992 Oct; 40(10):694-6. PubMed ID: 1307363 [TBL] [Abstract][Full Text] [Related]
13. Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures. Rajshekhar V Neurology; 1993 Jun; 43(6):1238-40. PubMed ID: 8170573 [TBL] [Abstract][Full Text] [Related]
14. Epilepsy due to neurocysticercosis: analysis of 203 patients. Del Brutto OH; Santibañez R; Noboa CA; Aguirre R; Díaz E; Alarcón TA Neurology; 1992 Feb; 42(2):389-92. PubMed ID: 1736171 [TBL] [Abstract][Full Text] [Related]
15. Albendazole therapy for neurocysticercosis. Sanchetee PC; Venkataraman S; Dhamija RM; Roy AK J Assoc Physicians India; 1994 Feb; 42(2):116-7. PubMed ID: 7860469 [TBL] [Abstract][Full Text] [Related]
16. Controversies in the treatment of seizures associated with neurocysticercosis. Singh G; Sharma R Epilepsy Behav; 2017 Nov; 76():163-167. PubMed ID: 28673685 [TBL] [Abstract][Full Text] [Related]
17. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Rajshekhar V; Jeyaseelan L Neurology; 2004 Jun; 62(12):2236-40. PubMed ID: 15210888 [TBL] [Abstract][Full Text] [Related]
18. Neurocysticercosis. Short course of treatment with albendazole. Alarcón F; Escalante L; Dueñas G; Montalvo M; Román M Arch Neurol; 1989 Nov; 46(11):1231-6. PubMed ID: 2818259 [TBL] [Abstract][Full Text] [Related]
19. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Carpio A; Santillán F; León P; Flores C; Hauser WA Arch Intern Med; 1995 Oct; 155(18):1982-8. PubMed ID: 7575052 [TBL] [Abstract][Full Text] [Related]
20. Antiepileptic drugs for seizure control in people with neurocysticercosis. Sharma M; Singh T; Mathew A Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]